Monthly Archives: September 2011

Infrared radiation from hot cones on cool conifers attracts seed-feeding insects. Insects with a taste for plants commonly respond to specific colours or odours associated with them. Cone-feeding western conifer seed bugs, however, have come up with a most unusual … Continue reading →

In an important finding published online in Developmental Cell, researchers at Albert Einstein College of Medicine of Yeshiva University, along with collaborators at Massachusetts Institute of Technology, have identified a protein likely responsible for causing breast cancer to spread. Metastatic … Continue reading →

454 Life Sciences, a Roche company, announced the publication of the 250th peer-reviewed study using the Genome Sequencer System. Researchers are taking advantage of the high accuracy and long reads that the Genome Sequencer FLX System provides to quickly generate … Continue reading →

Approximately 30% of Canadians suffer daily from chronic pain. Patients may be affected differently depending on the intensity, but all chronic pain is debilitating and difficult to treat. A study carried out by Louise Lamb, a clinician nurse at the … Continue reading →

Scientists have already hooked brains directly to computers by means of metal electrodes, in the hope of both measuring what goes on inside the brain and eventually healing conditions such as blindness or epilepsy. In the future, the interface between … Continue reading →

Mothers around the world now collectively can say, “I told you so.” Your vegetables are good for you, says a research review published by scientists from the University of Alabama at Birmingham in the journal Clinical Epigenetics. In particular, vegetables … Continue reading →

Whether it’s magnetic nanoparticles (mNPs) giving an army of ‘therapeutically armed’ white blood cells direction to invade a deadly tumour’s territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping … Continue reading →

Clinicians at St. Jude Children’s Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia. The St. Jude technique allows blood stem … Continue reading →

Gloucester Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) approved ISTODAX® (romidepsin) for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. The approval of ISTODAX was based … Continue reading →

Our DNA determines a lot about who we are and how we play with others, but recent studies of social animals (birds and bees, among others) show that the interaction between genes and behavior is more of a two-way street … Continue reading →